1. Home
  2. IROH vs ADAG Comparison

IROH vs ADAG Comparison

Compare IROH & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROH
  • ADAG
  • Stock Information
  • Founded
  • IROH 2021
  • ADAG 2011
  • Country
  • IROH United States
  • ADAG China
  • Employees
  • IROH N/A
  • ADAG N/A
  • Industry
  • IROH
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • IROH
  • ADAG Health Care
  • Exchange
  • IROH Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • IROH 91.2M
  • ADAG 81.9M
  • IPO Year
  • IROH 2023
  • ADAG 2021
  • Fundamental
  • Price
  • IROH $10.39
  • ADAG $1.76
  • Analyst Decision
  • IROH
  • ADAG Strong Buy
  • Analyst Count
  • IROH 0
  • ADAG 1
  • Target Price
  • IROH N/A
  • ADAG $8.00
  • AVG Volume (30 Days)
  • IROH 33.8K
  • ADAG 151.8K
  • Earning Date
  • IROH 01-01-0001
  • ADAG 03-09-2025
  • Dividend Yield
  • IROH N/A
  • ADAG N/A
  • EPS Growth
  • IROH N/A
  • ADAG N/A
  • EPS
  • IROH 0.20
  • ADAG N/A
  • Revenue
  • IROH N/A
  • ADAG $815,746.00
  • Revenue This Year
  • IROH N/A
  • ADAG N/A
  • Revenue Next Year
  • IROH N/A
  • ADAG $2.70
  • P/E Ratio
  • IROH $53.09
  • ADAG N/A
  • Revenue Growth
  • IROH N/A
  • ADAG N/A
  • 52 Week Low
  • IROH $9.97
  • ADAG $1.64
  • 52 Week High
  • IROH $11.11
  • ADAG $3.66
  • Technical
  • Relative Strength Index (RSI)
  • IROH N/A
  • ADAG 42.36
  • Support Level
  • IROH N/A
  • ADAG $1.64
  • Resistance Level
  • IROH N/A
  • ADAG $1.95
  • Average True Range (ATR)
  • IROH 0.00
  • ADAG 0.10
  • MACD
  • IROH 0.00
  • ADAG 0.00
  • Stochastic Oscillator
  • IROH 0.00
  • ADAG 37.50

About IROH Iron Horse Acquisitions Corp. Common Stock

Iron Horse Acquisitions Corp is a blank check company.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: